Our guest this episode is Dr. Elizabeth Neyens, a toxicological pathologist who focuses on pre-clinical research, histopathological evaluation, due diligence, digital pathology as well as quality assurance expertise.

This episode we will look at toxicological pathology and the role of digital pathology in drug development. We will discuss the job of a toxicological pathologist and how it has shifted during COVD-19. We will also look at the use of artificial intelligence in drug development.